[HTML][HTML] Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review
P Siriratnam, S Huda, H Butzkueven… - Autoimmunity …, 2023 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare central nervous system
autoimmune disease. Aquaporin-4 antibody (AQP4-IgG) is present in over 75% of cases and …
autoimmune disease. Aquaporin-4 antibody (AQP4-IgG) is present in over 75% of cases and …
Topical review: Lactation and use of DMTs in women with MS
S Hsu, A Balan, R Bove - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
One in three females with multiple sclerosis (MS) becomes pregnant after diagnosis. In the
postpartum period, there is a risk of rebound inflammatory activity. This risk can likely be …
postpartum period, there is a risk of rebound inflammatory activity. This risk can likely be …
[HTML][HTML] Recommendations for the Treatment of Multiple Sclerosis in Family Planning, Pregnancy and Lactation in Switzerland: Immunotherapy
M Graber, A Panchaud, H Legardeur, T Derfuss… - Clinical and …, 2024 - mdpi.com
A large number of disease-modifying immunotherapies are available for the treatment of
people with multiple sclerosis. Many disease-modifying immunotherapies show scarce or no …
people with multiple sclerosis. Many disease-modifying immunotherapies show scarce or no …
[HTML][HTML] Post-Partum Clinical and Patient-Reported Outcome Changes in Mothers with Multiple Sclerosis: Findings from the NAPPREMS Study
D Jakimovski, KS Kavak, K Patrick, O Mirmosayyeb… - Medicina, 2024 - mdpi.com
Background and Objective: Pregnancy in mothers with multiple sclerosis (MS) commonly
results in significant changes in disease activity and changes in clinical care, including the …
results in significant changes in disease activity and changes in clinical care, including the …
Schwangerschaft und Stillzeit bei Frauen mit Multipler Sklerose
L Witt, S Thiel, K Hellwig - Der Nervenarzt, 2024 - Springer
Zusammenfassung Die Diagnose Multiple Sklerose (MS) bei Frauen im reproduktiven Alter
ist mit vielen Unsicherheiten in Bezug auf Kinderwunsch und Stillzeit verbunden …
ist mit vielen Unsicherheiten in Bezug auf Kinderwunsch und Stillzeit verbunden …
[PDF][PDF] Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date
R Bove, C Pietrasanta, C Oreja-Guevara… - Presented at the 76th … - medically.gene.com
Background HCP, healthcare professional; MS, multiple sclerosis; US, United States. 1. F.
Hoffmann La-Roche Ltd. https://www. ocrelizumabinfo. global/. Accessed March 2024; 2 …
Hoffmann La-Roche Ltd. https://www. ocrelizumabinfo. global/. Accessed March 2024; 2 …